Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Obseva Sa Ordinary Shares (OBSV)

6.5462 -0.6638 (-9.2067%)

6/26/2017  12:46pm

Open:

7.0206

Pre. Close:

7.2100

High:

7.0206

Low:

6.3516

Volume:

8,542

Market Cap:

174.28M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-06-26 12:23:55 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 8.91     One year: 10.82

Support:

Support1: 5.00    Support2: 4.16

Resistance:

Resistance1: 7.63    Resistance2: 9.26

Pivot:

6.67

Moving Averages:

MA(5): 6.29     MA(20): 7.12

MA(100): 9.57     MA(250):

MACD:

MACD(12,26): -0.48     Signal(12,26,9): -0.48

%K %D:

%K(14,3): 42.33     %D(3): 33.72

RSI:

RSI(14): 45.20

52-Week:

High: 14.6950  Low: 5.0000  Change(%): -43.9

Average Vol(K):

3-Month: 28  10-Days 78

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
OBSV has closed above bottom band by 46.9%. Bollinger Bands are 0% narrower than normal.

Headline News

Thu, 11 May 2017 11:04:27 GMT
ObsEva SA to Hold First Quarter 2017 Financial Results and Business Update ...

Wed, 07 Jun 2017 11:03:45 GMT
ObsEva SA Announces the Completion of a Phase 1 PK/PD Clinical Trial ...

Fri, 03 Feb 2017 12:00:00 GMT
ObsEva SA to Attend LEERINK Partners Global Healthcare Conference in NYC

Thu, 26 Jan 2017 04:07:23 GMT
ObsEva SA Announces Pricing of Initial Public Offering

Thu, 18 May 2017 10:47:10 GMT
BRIEF-Obseva SA says it intends to advance OBE022 into Phase 2A proof-of ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

29.63

Shares Float (M)

8.41

% Held by Insiders

% Held by Institutions

Shares Short (K)

18

Shares Short Prior Month (K)

10

Stock Financials

EPS

-1.790

EPS Est. Current Year

-2.110

EPS Est. Next Year

-2.070

EPS Est. Next Quarter

-0.460

Forward EPS

-2.069

Book Value (p.s.)

4.190

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

Return on Equity (ttm)

-46.6

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.398

Qtrly Earnings Growth

Operating Cash Flow (M)

-34.40

Levered Free Cash Flow (M)

FoxReading.com

Valuation

P/E

-3.65

P/E Growth Ratio

-0.09

P/BV

1.56

P/S

P/CF

-5.63

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.